Abavine 600 Tablet contains Abacavir 600mg, a key antiretroviral used in combination therapy for managing HIV infection. It helps reduce viral load and enhances the functioning of the immune system, improving long-term treatment outcomes.
Abacavir is part of the NRTI (Nucleoside Reverse Transcriptase Inhibitor) class, known for its strong efficacy, predictable absorption, and sustained activity. It supports therapy goals by helping patients maintain viral suppression and better immune recovery.
For distributors and franchise partners, Abavine 600 is a high-consumption, year-round demand product due to the continuous nature of ART therapy. HIV patients depend on uninterrupted medication, generating consistent prescription flow and repeat orders.
Offering Abavine 600 strengthens a supplier’s presence in the antiretroviral and chronic-care market, expanding opportunities in hospital supply, clinics, government tenders, and long-term therapy management—making it a reliable business-growing product.